Multi-agent collaboration reshapes medical AIâTsinghua AIR incubates Doctorâ¯Aâs digital twin to see patients in hospitals.
Multi-Agent Collaborative Reconstruction of Medical AI! Tsinghua AIR Incubates: Doctor A’s Avatar “Consults” at Hospitals
Summary
鹭羽 发自 凹非寺量子位 | 公众号 QbitAI不会……只有我这样做吧?现在每次去医院看病前,我都会让AI帮我跑一轮。哪里不舒服、持续了多久,还包括既往病史,
鹭羽 发自 凹非寺
量子位 | 公众号 QbitAI
不会……只有我这样做吧?
现在每次去医院看病前,我都会让AI帮我跑一轮。
哪里不舒服、持续了多久,还包括既往病史,这些零零碎碎的信息,都在预问诊阶段准备妥帖。
等到和医生面对面,结果发现医生也在Vibe Working:
Agent协助医生下判断,诊室之外的随访与健康信息管理也由AI跟上。
乍一听有点赛博朋克,但却是实实在在发生在现实的一幕。
张亚勤院士创办的清华AIR,最近又跑出来一家明星AI医疗企业——
紫荆智康。
其研发的“紫荆AI医院”系统,已经在全国各地的医院陆续上线测试。
走进去更科幻更未来的是,这里的每个医生都能拥有辅助自己工作的专属AI分身,但这还远远不够。
单说咱去看病,一个毛病可能就同时牵扯到多个科室。
医学又是最讲究专业实力的,总不能让骨科医生来给你看肺部问题……
所以当不同专长的医生拥有各自的分身,这些分身之间又能否进一步协作?
围绕这个问题,紫荆智康此次带来了医学领域的多分身智能体协同技术(Multidisciplinary Human-Agent Collaboration),并进一步升级“紫荆AI医院”(Agent Hospital)。
AI医院里,AI医生与人类医生通力合作……一个连接真实诊疗、能够持续进化的虚拟医疗世界,正逐渐成形。
将多科室的专业判断,带进同一间诊室
先说老问题。
医疗行业有个绕不开的现实:好医生永远稀缺。
每个医生都有自己的专攻方向,每家医院也有着各自的资源承载上限。
看病难,难如上青天。
通常一个患者的病症如果横跨多个科室,现实路径是这样的:
先挂内科,查不出所以然转外科,外科看完再约影像科,几个科室的号都挂遍了,才轮得上发起一次正式的多学科会诊(MDT)。
结果到头来,最佳治疗窗口可能已经错过了。
而且一次MDT本身也不便宜,光凑齐各科专家的时间,就得付一笔不低的会诊费。
紫荆智康的思路比较直接,既然让患者去找专家不太现实,那不如先让专家分身集体到位。
碰到同科室就能解决的病症时,单个AI分身就管用。
相当于把高水平专家的AI分身请进普通门诊,为当前医生提供指导建议。
反之如果是那些跨学科的复杂问题,紫荆智康则干脆给这些分身搭了个多学科协作会议。
当具备不同专长的Agent分身依次加入分析,单一医生能获得的专业视角直接被大幅度拓宽。
这样,在同一套操作系统的调度下,AI分身既能实现同科支持,也能跨科参与。
举个例子,现在有位因甲亢进入内分泌科的患者,在问诊过程中,系统同步收集到患者还兼有哮喘病史的信息。
对当前诊室而言,后续处置就需要同时考虑呼吸系统的情况。
于是呼吸科分身介入,提醒医生关注后续用药的相关风险。
这就是多分身智能体协同的基本逻辑,它能够把跨专科支持前置到首诊、预问诊这些更早的环节。
换句话说,患者走进这间诊室时,就有一整个医生团队在打辅助,那些疑难重症专属的多学科支持就有可能成为日常诊疗的标配。
具体怎么协同的?紫荆智康提供了两种形态。
一种是按需提醒。
医生还是照常进行门诊,随着患者不断提供新信息,系统识别其它专科参与的需要,再把相关分身的意见以提醒方式呈现给医生。
期间并不会打断原有的诊疗流程。
另一种是会诊模式。
对于已经明确需要多个专科共同分析的病例,多个分身直接参与其中,并在界面上围绕诊断、用药等环节呈现对应建议。
医生要做的,就是用自己的专业知识,比较权衡这些不同视角。
当然,意见多了,还会产生另一个问题:分身之间说得不一样,咋办?
老实说,紫荆智康的处理方式挺反直觉。
它没有主动去收敛分歧,而是把分歧明明白白摆出来。
系统会分别呈现不同分身的建议,对不一致之处高亮提醒。医生能够看到意见来自哪个分身,再结合患者情况、相关依据及自己的经验,完成最终判断。
因为差异本身也有价值。
有位内科执业医师就表示,AI现阶段的重要帮助,还是补充医生可能没有想到的方向:
当AI建议跟我的判断不完全一致时,我会回顾输入的信息,看看是什么原因。
如果它根据现有资料给出的想法和我倾向的事情是不同方向的,我会觉得很有意义。
接下来我就需要非常慎重地去鉴别到底哪一个更符合实际情况。
所以多分身协同的价值,最终还是要落在后续研判过程上。
对比其它医疗Agent,这也是紫荆智康的系统能够更好地补全专业视角、提供可追溯源头的核心所在。
事实上,这也并非紫荆智康一家之言。
把多个AI角色组织起来,本身已经成为医疗AI的重要探索方向之一。
比如微软在MAI-DxO研究中,通过模拟医生团队,围绕病例逐步获取信息、提出诊断假设并选择检查,以此研究诊断准确性与成本之间的关系。
紫荆智康进一步强调的,则是分身与具体医生之间的联系。
这里的医生分身会在基础能力之上,持续学习真人医生,完成自进化成长,最终再将决策权交还给真人医生。
从这个角度看,多分身协同恰恰超越了“用AI替代医生”的传统叙事,实则让每个医生的背后,都站着一整个随叫随到的专家团队。
底座成型,让AI分身持续成长
不过要让成百上千个分身随时在线、各司其职,背后还需要一套完整系统。
分身从哪里获得能力,如何理解不断增加的患者信息,怎样适应医生的工作习惯,又如何接入医院原有流程……环环相扣,都会影响最终的使用效果。
这也是紫荆智康构建紫荆AI医院生态的原因。
类似的医疗智能体平台也有,比如微软的Healthcare Agent Orchestrator,会组织起不同的智能体处理信息,并围绕肿瘤会诊等复杂任务构建工作流。
紫荆AI医院的不同之处,在于其分身会在真实门诊的实践中不断成长。
这一核心技术路线,源自AIR刘洋教授团队在Agent Hospital构建之初提出的SEAL,即基于拟像的可进化智能体学习。
这是一套「虚拟世界训练+现实世界验证与微调」的双层进化架构。
在虚拟环境里,患者、医生、护士等角色均由智能体扮演。
AI医生每天在里面高强度模拟诊疗,数百万超拟真AI患者求医问药,组成闭环式医疗虚拟世界。
成功的案例可以进入病例库,供后续任务参考;出现问题时,再从失败中反思、提炼经验,并经过整理,逐步形成可复用的规则。
只要短短几天时间,AI医生智能体就能完成几十万甚至上百万案例,把罕见病、复杂病、多病程组合全部跑一遍。
类比AlphaGo的自我对弈,AI医生在虚拟医院里自我进化。能力稳步提升的同时,算力消耗也远低于传统大模型训练。
但虚拟世界训练出的早期AI也有明显问题,它会倾向于把各种可能性考虑得过度充分。
紫荆AI医院的首席产品官乔宇宸,就透露了这样一个有趣的小细节:
AI给医生推荐的是疗效最好的药,但医生考虑到患者的经济情况,最后换成了相对便宜、进了医保的药。
于是真实诊疗上场。
通过引入现实世界中的验证与伴生成长,系统让分身与真人医生一起工作,再把医生的操作反馈进内部微调。
Agent不仅行动像医生,思维也要和医生同步。
落到实际应用上,紫荆AI医院面向医生、患者、医院三端:
患者端负责预问诊、健康资料与后续管理;医生端承接分身、病历及决策辅助;医院端支持排班、权限与数据管理。
三端产品把底层能力带到了不同角色面前。继续接入专科工具和合作伙伴,则是在此基础上推进的下一步。
目前,这套系统已经在真实医院中交出了成绩单。
截至2026年7月,该系统已构建54位AI医生和数百万超拟真AI患者,覆盖数千种疾病。
北京清华长庚医院已有18个临床科室开展门诊测试,40余名医生常态化使用,医生整体诊疗效率能够提升30%。
基准测试方面,AI医生在MedQA数据集上的准确率超过96%,并在多个国际医学评测数据集中均取得最高成绩。
接下来要回答的,就是如何让这份专业支持走进更多医院,惠及更多患者。
AI医院的下一步,走向更多人
这些年来,医疗AI都偏向单打独斗。
厂商也好,医院也罢,都习惯从一个具体任务切入,比如影像识别、病历生成或辅助问诊。
但要说真看病,肯定是一连串的过程。
行业长期缺乏一套能够连接不同角色、贯穿诊疗流程的生产级AI原生系统。
就没人想做吗?那倒也未必,难就难在很少有人能把前沿技术、临床与工程绑在一起。
这是学术界与产业界共同面对的尴尬处境:
哈佛、MIT、斯坦福这些顶尖高校,的确拥有最完整的医学AI创新生态。但从实验走向临床,还缺乏系统工程验证。
顶尖医疗机构(如梅奥诊所、多伦多总医院、克利夫兰诊所)倒是坐拥深厚的临床资源,也有丰富的患者需求。
但它们缺少顶尖AI人才和技术,无法独立研制AI原生系统。
硅谷的AI科技巨头们走得会稍远一些,但医学只是它们布局的众多分支领域之一,缺乏体系级创新,也需要在实际诊疗中一步步理解和适配医疗流程。
生产级AI原生医疗系统的落地,需要让这些能力形成合力,所以当下紫荆智康是T0级别。
紫荆智康算是个新玩家,两年前才由清华智能产业研究院(AIR)孵化成立。
放在单项研究动辄十几年的医学领域,的确显得初出茅庐。
但团队的研究积累远早于此,成员本身长期扎根智慧医疗:
多篇论文相继登上《Nature Medicine》《NEJM AI》等医学AI顶刊。
其中,2024年海内外刷屏的Agent Hospital论文一炮而红,被称作“世界上第一个AI医院”。
相关实践还获得了《Nature》的重点关注,并被其列为AI虚拟分身落地医疗领域的核心参考案例。
紫荆智康算是非常典型的学术成果落地的成功范例。
从清华AIR出发,到登上顶刊,再到走进真实诊室,这支团队正在一步步将学术积累转化为医生和患者都用得上的产品。
One More Thing
在今天的发布会上,紫荆智康还有个关键特质让我很动容。
君子当以厚德载物,承袭自清华AIR的普惠特质,紫荆智康在技术的推进过程中,也始终没有落下医学的人文关怀。
紫荆智康主张,通过价值对齐,将医学人文理念转化为算法可理解、可执行的约束与偏好。
也就是说,系统在设计之初就牢牢锁定了AI与人的协同边界,遵循以人为本的导向,明确AI的辅助定位。
在智能体的构建上,也不追求全能且统一的超级AI,而是保留每个智能体的差异性与多样性,博采众家之长。
落到实处,就是专业级能力的下放,让更多基层医生、赤脚医生乃至乡镇机构都得以享受一线资源,是实实在在造福于广大患者。
诚然,这条路并不轻松,每一道合规关卡、每一位医生习惯的切换,都要在具体实践中打磨。
紫荆智康选择的这条从虚拟世界到真实诊室的路,更慢但也更稳。
不过可以预见的曙光是,当医生每多一份有效支持,患者就能少走一点弯路。
生命得以延续,科技的价值才得以真正彰显。
官网链接:https://www.tairex.cn/
一键三连「点赞」「转发」「小心心」
欢迎在评论区留下你的想法!
— 完 —
🌟 点亮星标 🌟
Now, before each hospital visit, I always let AI run a round for me.
Where it hurts, how long it’s lasted, plus medical history—these bits and pieces are all prepared during the pre‑consultation stage.
When I finally face the doctor, I find the doctor is also Vibe Working:
An agent assists the doctor in making judgments, and AI handles follow‑ups and health information management beyond the exam room.
At first glance it sounds a bit cyberpunk, but it’s a scene actually happening in reality.
Tsinghua AIR, founded by academician Zhang Yaqin, has recently produced another star AI medical company—
Zhijing Zhikang.
Their developed “Zhijing AI Hospital” system has already been rolled out for testing in hospitals across the country.
Even more sci‑fi and futuristic is that every doctor here can have a dedicated AI assistant to support their work, but that’s still far from enough.
Just consider a single visit: one ailment may involve multiple departments simultaneously.
Medicine is also the field that demands the highest professional expertise; you can’t have an orthopedic surgeon diagnose a lung problem…
So when doctors of different specialties each have their own digital avatars, can those avatars collaborate further?
Addressing this question, Zijing Zhikang presents the Multidisciplinary Human‑Agent Collaboration (Multidisciplinary Human-Agent Collaboration) technology in the medical field, and further upgrades the “Zijing AI Hospital” (Agent Hospital).
In AI hospitals, AI doctors collaborate closely with human doctors…a virtual medical world that connects real clinical care and can continuously evolve, is gradually taking shape.
Bringing multi‑department expert judgments into the same examination room
First, let’s address the old problem.
The healthcare industry has an unavoidable reality: good doctors are always scarce.
Each doctor has their own specialty, and each hospital has its own resource capacity limit.
Getting medical care is difficult, as hard as reaching the heavens.
Usually, when a patient’s condition spans multiple departments, the real‑world pathway looks like this:
First you see internal medicine, can’t find the cause so you’re referred to surgery, after surgery you schedule imaging, you’ve booked appointments in several departments, and only then can you initiate a formalmultidisciplinary consultation (MDT).
In the end, the optimal treatment window may already have been missed.
Moreover, a single MDT isn’t cheap; just coordinating the time of experts from each department incurs a substantial consultation fee.
Zijing Zhikang’s approach is straightforward: since it’s unrealistic to have patients seek out experts, why not first bring the experts’ avatars together?
When a condition can be resolved within the same department, a single AI avatar is sufficient.
It’s like inviting an AI replica of a top‑level specialist into a regular clinic to provide guidance and suggestions to the attending physician.
Conversely, for those interdisciplinary complex cases, Zijing Zhikang simply sets up amultidisciplinary collaboration meeting for these replicas.
As agents with different expertise join the analysis one after another, the professional perspective available to a single physician is dramatically broadened.
Thus, under the same operating system’s scheduling,the AI avatar can provide support within the same department and also participate across departments.
For example, a patient admitted to the endocrinology department for hyperthyroidism also has a history of asthma, which the system captures during the consultation.
For the current examination room, subsequent management must also take the respiratory system into account.
Thus, a respiratory specialist avatar intervenes, reminding doctors of the related risks of subsequent medication.
This is the basic logic of multi‑avatar intelligent agent collaboration, which canbring cross‑specialty support forwardto earlier stages such as the initial consultation and pre‑triage.
In other words, when a patient walks into this examination room, an entire medical team is already providing assistance, and the specialized multidisciplinary support for complex cases may become the norm in everyday clinical practice.
How exactly does the collaboration work? Zijing Zhikang provides two forms.
One is on‑demand reminders.
The doctor continues with regular outpatient visits, and as patients provide new information, the system identifies the need for involvement from other specialties and then presents the relevant consults as reminders to the doctor.
This does not interrupt the existing diagnostic and treatment workflow.
Another approach is the consultation mode.
For cases that clearly require analysis by multiple specialties, multiple avatars directly participate, and the interface presents corresponding recommendations around diagnosis, medication, and other steps.
What the doctor needs to do is use their professional knowledge to weigh these different perspectives.
Of course, with many opinions, another problem arises:the different personas say different things, what to do?
Honestly, Zijing Zhikang’s approach is quite counterintuitive.
It doesn’t actively try to converge the divergences; instead, it lays the differences out clearly.
The system presents the recommendations from each persona separately, highlighting any inconsistencies. The doctor can see which persona each opinion comes from and, together with the patient’s situation, relevant evidence, and personal experience, make the final judgment.
Because the differences themselves are valuable.
A practicing internist said that, at present, AI’s important assistance is still to supplement directions that doctors may not have considered:
When AI’s suggestions don’t fully align with my judgment, I review the input information to see what caused the discrepancy.
If the ideas it proposes based on existing data are in a different direction from what I tend to favor,I find that very meaningful.
Then I need to carefully determine which one actually reflects the reality.
Therefore, the value of multiple avatars collaborating ultimately depends on thesubsequent assessmentprocess.
Compared with other medical agents, this is also the core reason why Zijing Zhikang’s system can better supplement professional perspectives and provide traceable sources.
In fact, this is not only Zijing Zhikang’s claim.
Organizing multiple AI personas has already become one of the key research directions in medical AI.
For example, in Microsoft’s MAI‑DxO study, they simulate a team of doctors who gradually gather information about a case, propose diagnostic hypotheses, and select tests, to investigate the relationship between diagnostic accuracy and cost.
ZiJing ZhiKang further emphasizes the connection between the avatars and specific physicians.
The doctor avatars here will build on their basic capabilities, continuously learn from real doctors, achieve self‑evolutionary growth, and ultimately return decision‑making authority to the real doctors.
From this perspective, the collaboration of multiple avatars actually surpasses the traditional narrative of “using AI to replace doctors”; instead, it means that behind every doctor stands an entire on‑demand expert team.
Foundation Formed, Enabling AI Avatars to Continuously Grow
However, to keep hundreds or thousands of avatars online at all times, each performing its own duties, a complete system is required behind the scenes.
Where do the avatars get their capabilities, how do they interpret the ever‑growing patient information, how do they adapt to doctors’ work habits, and how are they integrated into existing hospital workflows… each link is interconnected and will affect the final user experience.
This is also why Zijing Zhikang is building the Zijing AI Hospital Ecosystem.
There are similar medical agent platforms, such as Microsoft’s Healthcare Agent Orchestrator, which coordinates different agents to process information and builds workflows around complex tasks like tumor consultations.
What sets Zijing AI Hospital apart is that its avatars continuously evolve through real outpatient practice.
This core technical roadmap originates from the SEAL proposed by Professor Liu Yang’s AIR team at the inception of building Agent Hospital, which stands for evolvable agent learning based on simulacra.
It is a dual‑layer evolutionary architecture of “virtual world training + real‑world validation and fine‑tuning”.
In the virtual environment, roles such as patients, doctors, and nurses are all played byintelligent agents.
AI doctors conduct high‑intensity simulated diagnosis and treatment daily, with millions of ultra‑realistic AI patients seeking medical advice, forming a closed‑loop virtual medical world.
Successful cases can be added to the case library for future reference; When problems arise, they are reflected upon and distilled from failures, and after organization, gradually form reusable rules.
In just a few short days, the AI doctor agent can complete hundreds of thousands, even millions of cases, running through all rare diseases, complex diseases, and multiple disease-course combinations.
Analogous to AlphaGo’s self‑play, the AI doctor evolves autonomously in a virtual hospital. While its capabilities steadily improve, the computational cost is far lower than traditional large‑model training.
However, early AI trained in the virtual world has obvious issues; it tends to consider every possibility overly exhaustively.
Qiao Yuchen, Chief Product Officer of Bauhinia AI Hospital, revealed this interesting detail:
The AI recommends the most effective medication to doctors, but the doctor, considering the patient’s financial situation, ultimately switches to a relatively cheaper, insurance‑covered drug.
Thus real‑world treatment steps in.
By introducing real-world validation and co‑evolution, the system lets the avatar work alongside real doctors, and feeds the doctors’ actions back into internal fine‑tuning.
The agent not only acts like a doctor, but its thinking must also be synchronized with doctors.
In practical application, the Zijing AI Hospital serves three sides: doctors, patients, and hospitals:
Patient side handles pre‑consultation, health records, and follow‑up management; Doctor side takes on avatars, medical records, and decision support; Hospital side supports scheduling, permissions, and data management.
The three‑side products bring underlying capabilities to each role. Continuing to integrate specialty tools and partners is the next step built on this foundation.
Currently, this system has already delivered results in real hospitals.
As of July 2026, the system has built 54 AI doctors and millions of hyper‑realistic AI patients, covering thousands of diseases.
Beijing Tsinghua Chang Gung Hospital already has 18 clinical departments conducting outpatient tests, with over 40 doctors using it routinely, and overall physician diagnostic efficiency can be improved by 30%.
In benchmark testing, AI Doctor achieves an accuracy exceeding 96%, and attains top scores across multiple international medical evaluation datasets.
The next question is how to bring this professional support into more hospitals and benefit more patients.
The next step for AI hospitals: reaching more people
In recent years, medical AI has tended to operate in isolation.
Whether it’s vendors or hospitals, they’re accustomed to starting with a specific task, such as image recognition, medical record generation, or assisted consultation.
But when it comes to actual diagnosis, it’s definitely a series of processes.
The industry has long lacked a production‑grade AI‑native system that can connect different roles and span the entire clinical workflow.
Does that mean no one wants to build it? Not necessarily; the difficulty lies in the fact that few can tie cutting‑edge technology, clinical practice, and engineering together.
This is the awkward situation faced jointly by academia and industry:
Harvard, MIT, Stanford and other top universities, indeed have the most comprehensive medical AI innovation ecosystem. However, moving from experiments to clinical practice still lacks systematic engineering validation.
Top medical institutions(such as Mayo Clinic, Toronto General Hospital, Cleveland Clinic) do have deep clinical resources and abundant patient demand.
But they lack top AI talent and technology, so they cannot independently develop AI-native systems.
AI tech giants in Silicon Valley may go a bit farther, but medicine is just one of many areas they are venturing into; they lack system-level innovation and need to gradually understand and adapt to medical workflows in real clinical practice.
The deployment of production-grade AI-native medical systems requires these capabilities to work together, so currently Zijing Zhikang is at T0 level.
Zijing Zhikang is a new player, having been incubated and founded byTsinghua Intelligent Industry Research Institute(AIR) just two years ago.
In a medical field where single‑topic research often spans decades, it indeed looks like a newcomer.
But the team’s research foundation predates this by far, and its members have long been rooted in smart healthcare:
Multiple papers have consecutively appeared in top medical AI journals such as Nature Medicine and NEJM AI.
Among them, the Agent Hospital paper that went viral worldwide in 2024 shot to fame and was dubbed the “world’s first AI hospital”.
The related work also received prominent attention from Nature and was listed as a core reference case for AI virtual avatars in the medical field.
Zijing Zhikang is a very typicalsuccessful example of academic成果落地.
Starting from Tsinghua AIR, reaching top journals, and entering real clinics, this team is gradually turning academic accumulation into products that both doctors and patients can use.
One More Thing
At today’s launch event, Zijing Zhikang displayed another key quality that moved me deeply.
A gentleman should bear the world with profound virtue, inheriting the inclusive qualities of Tsinghua AIR, Zijing Zhikang has never neglected the humanistic care of medicine throughout its technological advancement.
Zijing Zhikang advocates that, through value alignment, medical humanities concepts can be transformed into algorithmically understandable and actionable constraints and preferences.
In other words, the system is designed from the outset to firmly define the collaborative boundary between AI and humans, adhering to a human‑centric approach and clearly positioning AI as an aid.
In building agents, we alsodo not pursue an all-powerful, unified super AI, but retain the differences and diversity of each agent, drawing on the strengths of many.
In practice, this means delegating professional‑level capabilities so that more primary care doctors, barefoot doctors, and even township institutions can access frontline resources, truly benefiting a broad patient base.
Admittedly, this path is not easy; every compliance hurdle and every shift in doctors’ habits must be refined through concrete practice.
The path that Zijing Zhikang has chosen from the virtual world to the real clinic is slower but steadier.
However, the foreseeable dawn is that for each additional effective support a doctor receives, patients can avoid some detours.
When life can be prolonged, the value of technology is truly demonstrated.
Official website link: https://www.tairex.cn/
One-click Triple Action“Like” “Share” “Heart”
Feel free to leave your thoughts in the comments!
— End —
🌟 Light Up the Star ⭐️
Get MirrorSpeed
Get MirrorSpeed